Mictura-8
Reduces the Need for BPH Related Surgery

Composition : Silodosine 8mg.

Form : Tablets / Pack : 10 x 10's / Type : ALU-ALU

Description : Silodosin, is a medication for the symptomatic treatment of benign prostatic hyperplasia. It acts as an α1A-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate), has been approved by the FDA since October 2008 at a recommended dose of 8 mg orally once daily. Clinical studies have shown that this selective α1A-AR is very attractive and more effective than placebo for voiding and storage symptoms in LUTS arising from BPH. Silodosin has excellent early efficacy, and is at least as effective as for other α1-blockers. Silodosin distinguishes itself by a strong effect not only on symptoms but also on obstruction as measured by pressure flow studies- Drug Des Devel Ther. 2010; 4: 291–297.

View more products with following salts